Ledger.Open graph →
SEC Form D · Amendment · filed March 5, 2020

Redmile Biopharma Investments II, L.P

Offering
$675.4M
Sold
$675.4M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
San Francisco, CA
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jeremy Green · San Francisco, CAExecAmrit Nagpal · San Francisco, CAExecMike Lee · San Francisco, CAExecRedmile Group, Llc · San Francisco, CAExecRedmile Biopharma Investments Ii (Gp), Llc · San Francisco, CAPromoterJohn R. Lawson Ii · Newport News, VAExecMike Lee · San Francisco, CAExecScott B. Anchell · Newport News, VAExecRedmile Group, Llc · San Francisco, CAExecOliver R. Corbett · London, United KingdomExecRobert H. Orley · BLOOMFIELD HILLS, MIExecMichael Rosenberg · New York, NYExecRedmile Group, Llc · San Francisco, CAExecRedmile Biopharma Investments Ii (Gp), Llc · San Francisco, CAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗